38-520-0

SOCS1 Polyclonal Antibody, Invitrogen™

Manufacturer: Invitrogen

Select a Size

Pack Size SKU Availability Price
Each of 1 38-520-0-Each-of-1 In Stock ₹ 38,270.00

38-520-0 - Each of 1

₹ 38,270.00

In Stock

Quantity

1

Base Price: ₹ 38,270.00

GST (18%): ₹ 6,888.60

Total Price: ₹ 45,158.60

Antigen

SOCS1

Classification

Polyclonal

Conjugate

Unconjugated

Gene

Socs1

Gene Alias

CIS1; Cish1; Cish7; cytokine inducible SH2-containing protein 1; cytokine inducible SH2-containing protein 7; cytokine-inducible SH2 protein 1; JAB; JAK binding protein; JAK2-binding protein; JAK-binding protein; Socs1; SOCS-1; SSI1; SSI-1; STAT induced SH3 protein 1; STAT-induced STAT inhibitor 1; Suppressor of cytokine signaling 1; Tec-interacting protein 3; TIP3; TIP-3

Host Species

Rabbit

Purification Method

Antigen affinity chromatography

Regulatory Status

RUO

Gene ID (Entrez)

12703, 8651

Content And Storage

-20°C

Form

Liquid

Applications

Immunohistochemistry (Paraffin), Western Blot

Concentration

0.25 mg/mL

Formulation

PBS with 0.1% sodium azide; pH 7.4

Gene Accession No.

O15524, O35716

Gene Symbols

Socs1

Immunogen

Raised against the C-term of human SOCS1.

Quantity

100 μg

Primary or Secondary

Primary

Target Species

Human, Mouse

Product Type

Antibody

Isotype

IgG

Related Products

Img

Invitrogen

37-410-0

--

Img

Invitrogen

34-690-0

--

Img

Invitrogen

37-720-0

--

Img

Invitrogen

40-280-0

--

Img

Invitrogen

37-610-0

--

Img

Invitrogen

40-640-0

--

Img

Invitrogen

40-120-0

--

Img

Invitrogen

40-370-0

--

Description

  • The Suppressor of cytokine signaling (SOCS) and cytokine-inducible SH2 proteins are a family of intracellular proteins which regulate the immune cell responses to cytokines
  • SOCS1 acts to suppress dendritic cell (DC) as well as T cell hyperactivation following cytokine signaling by inhibiting JAK tyrosine kinase, a kinase necessary for type I and II cytokine receptors to initiate signaling, by directly binding to the catalytic domain of the kinase
  • SOCS1 also possesses E3 ubiquitin protein ligase activity that results in the polyubiquitination of its target proteins and subsequent degradation by the proteosome
  • It is through this method that SOCS1 negatively regulates signaling by Toll-like receptors TLR2 and TLR4 by mediating the degradation of the TLR signaling adaptor protein TIRAP.